BRIEF-Celgene says 2020 Revlimid forecast is conservative: conf call By: Reuters: Company News April 28, 2016 at 10:22 AM EDT April 28 (Reuters) - Celgene Execs Say Otezla Continues To Grow At Similar Rate After Novartis' Cosentyx Launch - Conf Call Read More >> Related Stocks: Celgene Corp